2 results
Approved WMOPending
This study is being performed to evaluate the cognitive and psychomotor effects of the new compound LY2624803 after bedtime dosing.
Approved WMOCompleted
To determine whether a second IVIg course in GBS patients with a poor prognosis improves functional outcome after 4 weeks.